AETHLON MEDICAL, INC. Cash and Cash Equivalents, Period Increase (Decrease)
AETHLON MEDICAL, INC. (AEMD) reported Cash and Cash Equivalents, Period Increase (Decrease) of $2.57 million for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-10.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-02-10
- 2020-12-31: Cash and Cash Equivalents, Period Increase (Decrease) 9 month $2.57M.
- 2019-12-31: Cash and Cash Equivalents, Period Increase (Decrease) 9 month $230.58K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|
| 2020-12-31 | $2.57M 10-Q · filed 2021-02-10 |
| 2019-12-31 | $230.58K 10-Q · filed 2021-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |